In this study, we examined the correlation between mTOR, HIF-1α, c-Myc, and PKM2 expression and the response to cisplatin-based NACT in patients with stage IB2 or IIA2 cervical cancer. The gene discussed is MYC; the disease is cervical carcinoma.